Efficacy of Adding Dexmedetomidine in Ultrasound-guided Intermediate Cervical Plexus Block for Thyroidectomy Surgery
Pain, Postoperative, Cancer of Larynx
About this trial
This is an interventional treatment trial for Pain, Postoperative focused on measuring Intermediate Cervical Plexus Block, dexmedetomidine, bupivacaine, Thyroidectomy surgery
Eligibility Criteria
Inclusion Criteria: Physical status American society Anesthesiologists ASA II and III. Age ≥ 18 and ≤ 60 Years. Patient undergoing thyroidectomy for cancer surgery. Exclusion Criteria: Patient refusal. Known sensitivity or contraindication to local anesthetics or dexmedetomidine. History of psychological disorders. Retro-sternal goiter and altered anatomical landmarks. Localized infection at the site of block. Coagulopathy with international normalized ratio (INR) ≥ 1.6: hereditary (e.g., hemophilia, fibrinogen abnormalities & deficiency of factor II) - acquired (e.g., impaired liver functions with prothrombin concentration less than 60 %, vitamin K deficiency & therapeutic anticoagulants drugs).
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Sham Comparator
Active Comparator
Group (A)
Group (B)
bupivacaine 0.25% only
bupivacaine 0.25% and dexmedetomidine